Choosing Optimal First-line Helicobacter pylori Therapy: a View from a Region with High Rates of Antibiotic Resistance

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|28|4510-4516

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.28, 2014-01, pp. : 4510-4516

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of first‐line bismuth‐containing 7‐day concomitant quintuple therapy for Helicobacter pylori eradication

By  

Journal of Digestive Diseases, Vol. 18, Iss. 12, 2017-12 ,pp. : 704-708

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combination therapy is preferred for the first-line treatment of hypertension in high-risk patients

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 7, 2010-07 ,pp. : 17-20

Adis International

Access to resources Recommend Favorite

Threshold Analysis of Helicobacter pylori Therapy

By Sonnenberg A.  

PharmacoEconomics, Vol. 14, Iss. 4, 1998-10 ,pp. : 423-432

Adis International

Access to resources Recommend Favorite

Evolving therapy for Helicobacter pylori infection

By Zullo Angelo   Hassan Cesare   Campo Salvatore MA   Morini Sergio  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 10, 2004-10 ,pp. : 1453-1464

Informa Healthcare

Access to resources Recommend Favorite

Spironolactone "safer first-line" therapy for hypertension

By  

Reactions Weekly, Vol. 1, Iss. 1254, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite